Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
-0.02 (-2.55%)
as of Nov 14, 2019

Values in US Thousands
  12-2018 12-2017 12-2016 12-2015
Sales $ 3,250 $ 5,069 $ 3,223 $ 610
Cost of Goods 10,052 9,345 6,920 4,596
Gross Profit -6,801 -4,277 -3,697 -3,986
Operating Expenses 17,509 17,243 15,248 13,021
Operating Income -24,259 -21,175 -18,025 -16,411
Interest Expense 311 483 526 640
Other Income/Expenses - 51 154 102
Pre-tax Income -24,570 -21,606 -18,397 -16,948
Income Taxes 2 8 -2 2
Net Income from Cont. Operations -24,572 -21,614 -18,395 -16,950
Total Net Income $ -24,572 $ -21,614 $ -18,395 $ -16,950
Basic EPS from Cont. Ops. -8.78 -23.58 -57.67 -92.33
Basic EPS from Total Ops. -9.01 -23.58 -57.66 -92.19
Diluted EPS from Cont. Ops -8.78 -23.58 -57.67 -92.33
Diluted EPS from Total Operations -9.01 -23.58 -57.66 -92.19
EBITDA -23,458 -20,599 -17,703 -16,149